New combo therapy shows promise for tough lung cancer
NCT ID NCT06477523
First seen May 03, 2026 · Last updated May 21, 2026 · Updated 3 times
Summary
This study tests a new treatment for people with extensive stage small cell lung cancer who have not had prior therapy. It combines an experimental drug (AK104) with standard chemotherapy and low-dose radiation. The goal is to see if this combination is safe and helps control the cancer longer. About 57 adults aged 18 to 80 are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLC, EXTENSIVE STAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
China West Hospital
Chengdu, Sichuan, 610000, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.